Drug Testing Locations - Avra Valley, AZ

Drug Testing in Avra Valley, AZ

Avra Valley, Arizona Statistics

Avra Valley, located in Pima County, AZ, has seen a 20% increase in opioid-related hospital admissions over the past year.

In Pima County, which includes Avra Valley, fentanyl seizures by law enforcement agencies increased by 30% in 2022.

Methamphetamine remains the second most common substance involved in drug-related deaths in Avra Valley, Pima County.

Youth drug use in Avra Valley, AZ, reflected a 15% increase in self-reported use of illicit drugs over the past year.

In Pima County, including Avra Valley, AZ, emergency room visits due to drug overdoses rose by 25% in the last year.

The rate of drug-related crimes in Avra Valley, AZ saw a 10% uptick in 2023, according to Pima County Sheriff's Department.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Avra Valley, AZ & Drug Testing Policies

Employers in Avra Valley, AZ are actively involved in mitigating drug problems within the workplace. Many businesses have adopted stringent drug testing policies as part of their employment process, reflecting a commitment to maintaining a drug-free environment.

Regular drug screenings are part of the pre-employment checks, and some employers also conduct random drug tests to deter substance abuse. Information about employment and labor rights can be found on the Industrial Commission of Arizona's website.

Such policies are often in alignment with state guidelines and are aimed at promoting safety and productivity. Employers emphasize the importance of accessing local addiction resources for employees who might be struggling, fostering a supportive work environment.

Government Efforts with Drug Problems in Avra Valley, AZ

In addressing the drug abuse issues in Avra Valley, AZ, the government has implemented various strategies. The Pima County Health Department has ramped up efforts to provide educational programs focused on substance abuse prevention and treatment. Resources are available on their official website.

The Arizona Department of Health Services has partnered with local organizations to enhance community outreach initiatives. Special grants have been allocated to support local rehab centers and provide Naloxone to first responders in Avra Valley. Additional details can be found on the Arizona DHS website.

Local Drug Busts & News in Avra Valley, AZ

Avra Valley, AZ, has witnessed several significant drug busts in recent years. In a notable operation, local law enforcement agencies seized large quantities of methamphetamine, highlighting the ongoing battle against drug trafficking in Pima County.

Community forums are periodically organized to address concerns and provide updates on the status of drug-related crimes. These events often feature detailed discussions on recent activities and are led by the Pima County Sheriff’s Department.

Drug-related events, including educational workshops and community cleanups, are frequently organized to raise awareness and involve the community in prevention efforts. These activities aim to inform residents about the dangers of drug abuse and offer support networks for affected individuals and families.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Avra Valley, AZ. Trusted by employers nationwide for accurate results and exceptional service.

Arizona DOT/Non DOT Physicals

Arizona Vision Tests

Arizona Audiograms

Arizona Respirator Fit Tests

Arizona Lift Tests

Arizona Background Checks

Clinical Testing Services

TB Testing in AZ

Diabetes Testing in AZ

Infectious Disease Testing in AZ

Sickle Cell Anemia Testing in AZ

Women/Men's Health Testing in AZ

Resources & Citations

The Haven

SAMHSA National Helpline

CODAC Health, Recovery & Wellness

Arizona Department of Health Services

Sage Counseling

Lifewell Behavioral Wellness

Carondelet Health Network

Community Bridges Inc.

Narcotics Anonymous

West Yavapai Guidance Clinic

Drug Testing Near Avra Valley, AZ

Three Points, AZ

Valencia West, AZ

Picacho, AZ

Oro Valley, AZ

Tucson Estates, AZ

Flowing Wells, AZ

Casas Adobes, AZ

Tortolita, AZ

Cortaro, AZ

Marana, AZ

Rillito, AZ

Picture Rocks, AZ

Nelson, AZ

Frequently Asked Questions

Customer Reviews